Diagnosis and management of central nervous system Sjögren's syndrome

2020 ◽  
pp. 189-209
Author(s):  
Pantelis P. Pavlakis ◽  
Theresa Lawrence–Ford ◽  
Shalini Mahajan ◽  
Janet Lewis ◽  
Arun Varadhachary ◽  
...  
2021 ◽  
Vol 12 ◽  
pp. 465
Author(s):  
Cylaina E. Bird ◽  
Jeffrey I. Traylor ◽  
Jenna Thomas ◽  
James P. Caruso ◽  
Benjamin Kafka ◽  
...  

Background: Primary peripheral T-cell central nervous system lymphoma (PCNSL) is a rare, aggressive tumor that arises in the craniospinal axis and has an increased risk in individuals who are immunocompromised. This lesion often mimics other benign and malignant processes on radiographic imaging, leading to misdiagnosis and delays in treatment. We present a case of a patient with a history of Sjögren’s syndrome and progressive neurologic symptoms who underwent craniotomy for diagnosis. Case Description: A 61-year-old woman with a history of Sjögren’s syndrome, progressive aphasia, left facial droop, and right-sided paresthesias for 4 months presented for evaluation and management. An enhancing, infiltrative lesion in the left frontal lobe with underlying vasogenic edema was appreciated and suggestive of a primary or metastatic neoplasm. The patient underwent an open biopsy for further evaluation of the lesion. Extensive histopathologic evaluation revealed a diagnosis of T-cell PCNSL. The patient was started on induction methotrexate and temozolomide followed by consolidative radiotherapy. Conclusion: Autoimmune conditions are a risk factor for T-cell PCNSL development. T-cell PCNSL has radiographic and gross histologic features that are consistent with a broad differential, including gliomas and inflammatory processes. Prompt diagnosis and extensive histopathological evaluation is essential to ensure appropriate treatment.


Sign in / Sign up

Export Citation Format

Share Document